Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS
文献类型：期刊论文
| 作者 | Xu, Pengfei; Yin, Qi ; Shen, Jianan; Chen, Lingli; Yu, Haijun; Zhang, Zhiwen; Li, Yaping
|
| 刊名 | INTERNATIONAL JOURNAL OF PHARMACEUTICS
 |
| 出版日期 | 2013-09-15 |
| 卷号 | 454期号:1页码:21-30 |
| 关键词 | Metastasis Silibinin TPGS Nanoparticles Breast cancer |
| ISSN号 | 0378-5173 |
| DOI | 10.1016/j.ijpharm.2013.06.053 |
| 文献子类 | Article |
| 英文摘要 | Tumor metastasis is the leading cause of breast cancer-related mortality and remains to be the principal obstacle for the successful chemotherapy of breast cancer. To block metastasis of breast cancer, silibinin-loaded lipid nanoparticles (SLNs) containing TPGS and phosphatidylcholine were designed and prepared by a thin-film hydration method. The optimized SLNs were approximately 45 nm in particle size with high stability in serum, which were further demonstrated to be efficiently uptaken by MDA-MB-231 breast cancer cells. Importantly, the SLNs could accumulate within tumor tissues with high efficiency and amounts. Compared with free silibinin, SLNs exhibited much stronger inhibitory effects on the invasion and migration of MDA-MB-231 cells through the downregulation of MMP-9 and Snail. More importantly, systematic in vivo evaluations demonstrated that SLNs treatment group resulted in 67% and 39% less pulmonary metastases formation than saline treatment group in the spontaneous and blood vessel metastasis models, respectively. Interestingly, the blank lipid nanoparticles without silibinin were also found, for the first time, to possess the efficient anti-metastatic capabilities to some extent. The biocompatibility assay reveals that SLNs treatment did not exhibit obvious systemic toxicity in two mouse models. Therefore, SLNs are the promising delivery systems against metastasis of breast cancer cells. (c) 2013 Elsevier B.V. All rights reserved. |
| WOS关键词 | EPITHELIAL-MESENCHYMAL TRANSITIONS ; LYMPH-NODE METASTASES ; E-CADHERIN EXPRESSION ; MOUSE PROSTATE MODEL ; VITAMIN-E TPGS ; TUMOR-GROWTH ; TRANSGENIC ADENOCARCINOMA ; MATRIX METALLOPROTEINASES ; CHITOSAN NANOSPHERES ; POLYMERIC MICELLES |
| 资助项目 | National Basic Research Program of China[2010CB934000] ; National Basic Research Program of China[2012CB932502] ; National Basic Research Program of China[2013CB932704] ; National Natural Science Foundation of China[30925041] ; National Natural Science Foundation of China[81270047] ; Shanghai Elitist Program[11XD1406200] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000323854600004 |
| 出版者 | ELSEVIER SCIENCE BV |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/277459]  |
| 专题 | 药物制剂研究中心 |
| 通讯作者 | Li, Yaping |
| 作者单位 | Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Xu, Pengfei,Yin, Qi,Shen, Jianan,et al. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS,2013,454(1):21-30. |
| APA | Xu, Pengfei.,Yin, Qi.,Shen, Jianan.,Chen, Lingli.,Yu, Haijun.,...&Li, Yaping.(2013).Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.INTERNATIONAL JOURNAL OF PHARMACEUTICS,454(1),21-30. |
| MLA | Xu, Pengfei,et al."Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS".INTERNATIONAL JOURNAL OF PHARMACEUTICS 454.1(2013):21-30. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。